Compare drug alternatives
Vyepti® Alternatives
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Ajovy®
(Fremanezumab)
Ajovy
-
Migraine
- Emgality®
- Aimovig®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Ajovy is a prescription medication that can be self-injected once a month or once every three months under the skin to prevent migraine headaches. The most commonly reported side effect is injection site reactions. Ajovy does not seem to cause constipation. Additionally, there are no known drug interactions.
Ajovy is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Intravenous infusion (must be diluted)
Subcutaneous
Dosing
100 mg every 3 months or 300 mg (for some patients)
225 mg monthly or 675 mg every 3 months (as three consecutive injections of 225 mg each)
Latin Shorthand
100 mg q3mo
225 mg/mo or 675 mg q3mo
Financial Assistance
Copay
$0
$5
Annual Cap
$200 per infusion for administration costs
Patient specific maximum benefit.
Assistance Expiration
Calendar year
12/31/2023
Generics
No lower-cost generic available
No lower-cost generic available